JP2014516701A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2014516701A5 JP2014516701A5 JP2014511880A JP2014511880A JP2014516701A5 JP 2014516701 A5 JP2014516701 A5 JP 2014516701A5 JP 2014511880 A JP2014511880 A JP 2014511880A JP 2014511880 A JP2014511880 A JP 2014511880A JP 2014516701 A5 JP2014516701 A5 JP 2014516701A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutically active
- active compound
- exendin
- peptide
- here
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 150000001875 compounds Chemical class 0.000 description 6
- 208000004476 Acute Coronary Syndrome Diseases 0.000 description 2
- 208000002249 Diabetes Complications Diseases 0.000 description 2
- 206010012689 Diabetic retinopathy Diseases 0.000 description 2
- 108010088406 Glucagon-Like Peptides Proteins 0.000 description 2
- JUFFVKRROAPVBI-PVOYSMBESA-N chembl1210015 Chemical compound C([C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)N[C@H]1[C@@H]([C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO[C@]3(O[C@@H](C[C@H](O)[C@H](O)CO)[C@H](NC(C)=O)[C@@H](O)C3)C(O)=O)O2)O)[C@@H](CO)O1)NC(C)=O)C(=O)NCC(=O)NCC(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](C)C(=O)N1[C@@H](CCC1)C(=O)N1[C@@H](CCC1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CO)C(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)CNC(=O)[C@@H](N)CC=1NC=NC=1)[C@@H](C)O)[C@@H](C)O)C(C)C)C1=CC=CC=C1 JUFFVKRROAPVBI-PVOYSMBESA-N 0.000 description 2
- 206010012601 diabetes mellitus Diseases 0.000 description 2
- 108010015174 exendin 3 Proteins 0.000 description 2
- LMHMJYMCGJNXRS-IOPUOMRJSA-N exendin-3 Chemical compound C([C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)NCC(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](C)C(=O)N1[C@@H](CCC1)C(=O)N1[C@@H](CCC1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CO)C(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC=1N=CNC=1)[C@H](C)O)[C@H](C)O)C(C)C)C1=CC=CC=C1 LMHMJYMCGJNXRS-IOPUOMRJSA-N 0.000 description 2
- PBGKTOXHQIOBKM-FHFVDXKLSA-N insulin (human) Chemical compound C([C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H]1CSSC[C@H]2C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@H](C(N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC=3C=CC(O)=CC=3)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC=3C=CC(O)=CC=3)C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=3C=CC(O)=CC=3)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=3NC=NC=3)NC(=O)[C@H](CO)NC(=O)CNC1=O)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(O)=O)C(=O)N[C@@H](CC(N)=O)C(O)=O)=O)CSSC[C@@H](C(N2)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@@H](NC(=O)CN)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)CC=1C=CC=CC=1)C(C)C)C1=CN=CN1 PBGKTOXHQIOBKM-FHFVDXKLSA-N 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 108090000765 processed proteins & peptides Proteins 0.000 description 2
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 1
- 208000035285 Allergic Seasonal Rhinitis Diseases 0.000 description 1
- 206010002383 Angina Pectoris Diseases 0.000 description 1
- 201000001320 Atherosclerosis Diseases 0.000 description 1
- 108010041986 DNA Vaccines Proteins 0.000 description 1
- 206010012655 Diabetic complications Diseases 0.000 description 1
- 208000005189 Embolism Diseases 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 108010011459 Exenatide Proteins 0.000 description 1
- 101000976075 Homo sapiens Insulin Proteins 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 108091034117 Oligonucleotide Proteins 0.000 description 1
- 208000010378 Pulmonary Embolism Diseases 0.000 description 1
- 208000001435 Thromboembolism Diseases 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229960001519 exenatide Drugs 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 239000004026 insulin derivative Substances 0.000 description 1
- 208000002780 macular degeneration Diseases 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 208000010125 myocardial infarction Diseases 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 206010039073 rheumatoid arthritis Diseases 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP11167533.6 | 2011-05-25 | ||
| EP11167533 | 2011-05-25 | ||
| PCT/EP2012/059751 WO2012160159A1 (en) | 2011-05-25 | 2012-05-24 | Medicament delivery device with cartridge sensor and cartridge holder door sensor and method of controlling the device |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2014516701A JP2014516701A (ja) | 2014-07-17 |
| JP2014516701A5 true JP2014516701A5 (cg-RX-API-DMAC7.html) | 2015-07-02 |
| JP6335779B2 JP6335779B2 (ja) | 2018-05-30 |
Family
ID=44652121
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014511880A Expired - Fee Related JP6335779B2 (ja) | 2011-05-25 | 2012-05-24 | カートリッジ・センサとカートリッジ・ホルダ・ドア・センサとを有する薬剤送達デバイスおよびこのデバイスを制御する方法 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US9504793B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP2714146B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP6335779B2 (cg-RX-API-DMAC7.html) |
| CN (1) | CN103717246B (cg-RX-API-DMAC7.html) |
| DK (1) | DK2714146T3 (cg-RX-API-DMAC7.html) |
| TR (1) | TR201807774T4 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2012160159A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9084849B2 (en) | 2011-01-26 | 2015-07-21 | Kaleo, Inc. | Medicament delivery devices for administration of a medicament within a prefilled syringe |
| US9522235B2 (en) | 2012-05-22 | 2016-12-20 | Kaleo, Inc. | Devices and methods for delivering medicaments from a multi-chamber container |
| EP2705863A1 (en) * | 2012-09-11 | 2014-03-12 | Sanofi-Aventis Deutschland GmbH | Medicament delivery device with needle alignment detection mechanism |
| EP2931336B1 (en) * | 2012-12-13 | 2017-06-14 | Medicom Innovation Partner a/s | Detection device and injection device comprising it |
| PT2945664T (pt) * | 2013-01-16 | 2019-06-04 | Bayer Pharma AG | Bloqueio para dispositivo injetor de fármaco |
| US10872350B1 (en) | 2013-12-06 | 2020-12-22 | Overstock.Com, Inc. | System and method for optimizing online marketing based upon relative advertisement placement |
| US10704944B2 (en) | 2014-09-14 | 2020-07-07 | Becton, Dickinson And Company | System and method for capturing dose information |
| US10971260B2 (en) | 2014-09-14 | 2021-04-06 | Becton, Dickinson And Company | System and method for capturing dose information |
| EP3193982B1 (en) * | 2014-09-15 | 2021-03-24 | Sanofi | Skin-attachable drug injection device with detachment sensor |
| US10730687B2 (en) * | 2014-10-16 | 2020-08-04 | RxCap Inc. | Intelligent medicine dispenser |
| CN107635527B (zh) | 2015-03-10 | 2021-04-23 | 里珍纳龙药品有限公司 | 无菌刺穿系统和方法 |
| WO2016154427A2 (en) | 2015-03-24 | 2016-09-29 | Kaleo, Inc. | Devices and methods for delivering a lyophilized medicament |
| CN107683158B (zh) | 2015-06-04 | 2021-05-14 | 麦迪麦珀医疗工程有限公司 | 用于药物释放装置的筒插入 |
| CN108140332A (zh) | 2015-06-19 | 2018-06-08 | 詹森药业有限公司 | 用于药物施用和混合的设备和方法及用于所述设备和方法的适当技术的训练 |
| EP3400045B1 (en) * | 2016-01-06 | 2020-05-06 | Sanofi-Aventis Deutschland GmbH | Medicament delivery device |
| US10967133B2 (en) * | 2016-05-30 | 2021-04-06 | Novo Nordisk A/S | Mounting feature for accessory device |
| CN109152884B (zh) | 2016-05-30 | 2022-02-11 | 诺和诺德股份有限公司 | 具有零位置调节特征的药物输送装置 |
| GB2606087B (en) | 2016-06-06 | 2023-03-08 | E3D Agricultural Cooporative Association Ltd | Multiple use computerized injector |
| HUE059229T2 (hu) | 2017-05-05 | 2022-10-28 | Regeneron Pharma | Automata befecskendezõkészülék |
| WO2019032512A1 (en) | 2017-08-10 | 2019-02-14 | West Pharma. Services IL, Ltd. | INJECTOR POWER-UP MECHANISM |
| JP7402799B2 (ja) | 2017-12-22 | 2023-12-21 | ウェスト ファーマ サービシーズ イスラエル リミテッド | サイズの異なるカートリッジを利用可能な注射器 |
| EP4035710B1 (en) * | 2019-09-25 | 2025-12-31 | Shenzhen Mindray Scientific Co., Ltd. | SYRINGE PUMP, SYRINGE PUMP SYSTEM, SYRINGE PUMP CONTROL METHOD AND STORAGE SUPPORT |
| CN112870535B (zh) * | 2021-01-18 | 2023-07-21 | 南京宽诚科技有限公司 | 释放盐溶胶的控制方法、装置、盐疗设备和存储介质 |
| US12214173B2 (en) * | 2021-06-08 | 2025-02-04 | Medtronic Minimed, Inc. | Injection pens for medicine administration and tracking |
| USD1007676S1 (en) | 2021-11-16 | 2023-12-12 | Regeneron Pharmaceuticals, Inc. | Wearable autoinjector |
| WO2024030811A2 (en) * | 2022-07-30 | 2024-02-08 | NovaXS Biotech Corp. | Needle-free injection system |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5478323A (en) | 1993-04-02 | 1995-12-26 | Eli Lilly And Company | Manifold for injection apparatus |
| DE69729300T2 (de) * | 1996-07-05 | 2005-08-04 | Novo Nordisk A/S | Dosiervorrichtung |
| GB0130140D0 (en) * | 2001-12-18 | 2002-02-06 | Dca Design Int Ltd | Improvements in and relating to medicament delivery service |
| GB0204673D0 (en) * | 2002-02-28 | 2002-04-10 | Dca Design Int Ltd | Improvements in and relating to a medicament delivery device |
| US7033338B2 (en) * | 2002-02-28 | 2006-04-25 | Smiths Medical Md, Inc. | Cartridge and rod for axially loading medication pump |
| EP1511526A1 (en) * | 2002-05-24 | 2005-03-09 | Eli Lilly And Company | Medical syringe pump with motor driven piston |
| BRPI0507550B8 (pt) * | 2004-02-18 | 2021-06-22 | Ares Trading Sa | dispositivo de injeção controlado eletronicamente, portátil |
| AU2010210160B2 (en) * | 2009-02-05 | 2014-09-04 | Sanofi-Aventis Deutschland Gmbh | Medicament delivery devices |
| CN101862489B (zh) * | 2010-06-13 | 2012-01-11 | 江苏华阳电器有限公司 | 一种药剂注射器 |
-
2012
- 2012-05-24 WO PCT/EP2012/059751 patent/WO2012160159A1/en not_active Ceased
- 2012-05-24 TR TR2018/07774T patent/TR201807774T4/tr unknown
- 2012-05-24 US US14/119,210 patent/US9504793B2/en not_active Expired - Fee Related
- 2012-05-24 EP EP12723203.1A patent/EP2714146B1/en not_active Not-in-force
- 2012-05-24 JP JP2014511880A patent/JP6335779B2/ja not_active Expired - Fee Related
- 2012-05-24 CN CN201280037491.6A patent/CN103717246B/zh not_active Expired - Fee Related
- 2012-05-24 DK DK12723203.1T patent/DK2714146T3/en active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2014516700A5 (cg-RX-API-DMAC7.html) | ||
| JP2014519900A5 (cg-RX-API-DMAC7.html) | ||
| JP2014516702A5 (cg-RX-API-DMAC7.html) | ||
| JP2014516701A5 (cg-RX-API-DMAC7.html) | ||
| Kaur et al. | Developments of Polysorbate (Tween) based microemulsions: Preclinical drug delivery, toxicity and antimicrobial applications | |
| JP2014531949A5 (cg-RX-API-DMAC7.html) | ||
| Moscona | Medical management of influenza infection | |
| CN115916772A (zh) | 6-氧代-3,6-二氢吡啶类衍生物、其制备方法及其在医药上的应用 | |
| CY1125006T1 (el) | Λιπαρα οξεα και η χρηση τους σε συνδυασμο με βιομορια | |
| Yang et al. | Engineering a long-acting, potent GLP-1 analog for microstructure-based transdermal delivery | |
| CN114901681A (zh) | 胰岛素衍生物 | |
| JP2010515677A5 (cg-RX-API-DMAC7.html) | ||
| Sanford | Dulaglutide: first global approval | |
| JP2007517016A5 (cg-RX-API-DMAC7.html) | ||
| EA201692282A1 (ru) | Композиция для лечения сахарного диабета, содержащая инсулин и двойной агонист glp-1/глюкагона | |
| JP2018531984A5 (cg-RX-API-DMAC7.html) | ||
| JP2019514979A5 (cg-RX-API-DMAC7.html) | ||
| NO20084919L (no) | Oksadiazolidindionforbindelse | |
| JP2013503202A5 (cg-RX-API-DMAC7.html) | ||
| JP2013533268A5 (cg-RX-API-DMAC7.html) | ||
| JP2018507914A5 (cg-RX-API-DMAC7.html) | ||
| JP2012520866A5 (cg-RX-API-DMAC7.html) | ||
| JP2011241213A5 (cg-RX-API-DMAC7.html) | ||
| AR047669A1 (es) | Entidad seleccionada entre un compuesto de xantina y un derivado fisiologicamente funcional del mismo, su uso para la fabricacion de un medicamento, formulacion farmaceutica y combinacion de formulaciones que la comprenden y metodo para su preparacion | |
| JP2014532722A5 (cg-RX-API-DMAC7.html) |